IDH2 and central nervous system cancer: The IDH-mutant grade 2-gliomas are classified into two subtypes which demonstrate different clinicopathological and genetic characteristics depending on the presence of co-deletion of the short arm of chromosome 1 (1p) and the long arm of chromosome 19 (19q) (1p/19q) according to the revised WHO classification [4].